Item Details

Revitalizing New Product Development From Clinical Trials Through FDA Review: Hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, Second Session, on S. 1477 ... February 21, 1996

United States. Congress. Senate. Committee on Labor and Human Resources
Format
Book; Government Document; Online; EBook
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.
Language
English
Series
S. Hrg
ISBN
0160526280
SuDoc Number
Y 4.L 11/4:S.HRG.104-444
Description
iii, 230 p. : ill. ; 24 cm.
Mode of access: Internet.
Notes
  • Shipping list no.: 96-0240-P.
  • Distributed to some depository libraries in microfiche.
  • Includes bibliographical references (p. 152-153).
Series Statement
S. hrg. ; 104-444
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 02433nam a2200565 a 4500
    001 003479147
    003 MiAaHDL
    005 20130211000000.0
    006 m d
    007 cr bn ---auaua
    008 000522s1996 dcua b f000 0 eng c
    010
      
      
    a| 96164615
    020
      
      
    a| 0160526280
    035
      
      
    a| (MiU)003479147
    035
      
      
    a| sdr-miu003479147
    035
      
      
    a| sdr-ucr.b25592865
    035
      
      
    a| sdr-pst.a1620709
    035
      
      
    a| (OCoLC)34928168
    040
      
      
    a| DGPO/DLC c| GPO d| DLC d| EYM
    043
      
      
    a| n-us---
    050
    0
    0
    a| KF26 b| .L27 1996g
    074
      
      
    a| 1043-B (MF)
    074
      
      
    a| 1043-A
    082
    0
    0
    a| 344.73/0423 2| 21
    086
    0
      
    a| Y 4.L 11/4:S.HRG.104-444
    110
    1
      
    a| United States. b| Congress. b| Senate. b| Committee on Labor and Human Resources.
    245
    1
    0
    a| Revitalizing new product development from clinical trials through FDA review : b| hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, c| 1996.
    300
      
      
    a| iii, 230 p. : b| ill. ; c| 24 cm.
    490
    0
      
    a| S. hrg. ; v| 104-444
    500
      
      
    a| Shipping list no.: 96-0240-P.
    500
      
      
    a| Distributed to some depository libraries in microfiche.
    504
      
      
    a| Includes bibliographical references (p. 152-153).
    538
      
      
    a| Mode of access: Internet.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    2
    a| Drug Evaluation x| legislation & jurisprudence z| United States.
    650
      
    0
    a| Biological products x| Safety regulations z| United States.
    650
      
    0
    a| Medical instruments and apparatus x| Safety regulations z| United States.
    650
      
    0
    a| Drugs x| Testing x| Law and legislation z| United States.
    650
      
    0
    a| Drugs x| Law and legislation z| United States.
    974
      
      
    b| MIU c| MIU d| 20170415 s| google u| mdp.39015042562838 y| 1996 r| pd q| bib
    974
      
      
    b| UC c| UCR d| 20180913 s| google u| uc1.31210014037749 y| 1996 r| pd q| bib
    974
      
      
    b| PST c| PST d| 20141114 s| google u| pst.000025634747 z| 4.L 11/4:S.HRG.104-444 y| 1996 r| pd q| bib

Access online

Google Preview